DECURA PHARMA: what changed
You see two financial years side by side: what moved most in the balance sheet and the result, why the result rose or fell and where the money went.
What changed
DECURA PHARMA
NACE 64.210, Activities of holding companies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€271,335
2024 · €108,814+€162,521
Equity
€3.8m
2024 · €3.6m+€271,335
Cash
€16,015
2024 · €69,549-€53,534
Balance sheet total
€10.9m
2024 · €8.8m+€2.1m
Largest movements
Assets
- Tangible fixed assets +€2.1m
up €2.1m (+61.0%), from €3.4m to €5.5m
of which Assets under construction and advance payments: +€2.2m
- Financial fixed assets +€247,368
up €247,368 (+6.6%), from €3.8m to €4.0m
- Receivables within one year -€227,318
down €227,318 (-24.7%), from €921,491 to €694,173
of which Other amounts receivable: -€299,454
Equity and liabilities
- Debts after one year +€1.0m
up €1.0m (+65.0%), from €1.6m to €2.6m
- Other debts +€409,104
up €409,104 (+16.4%), from €2.5m to €2.9m
- Trade debts +€328,274
up €328,274 (+166%), from €197,915 to €526,188
- Reserves +€271,335
up €271,335 (+7.7%), from €3.5m to €3.8m
of which Distributable reserves: +€304,221
Income statement
- Gross operating margin +€210,163
up €210,163 (+49.4%), from €425,832 to €635,995
- Taxes +€49,276
up €49,276 (+74.8%), from €65,862 to €115,138
- Financial income -€8,795
down €8,795 (-33.8%), from €26,035 to €17,239
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€108,814
Gross operating margin
+€210,163
Depreciation
+€5,372
Other operating charges
+€6,069
Financial income
-€8,795
Financial charges
-€1,013
Taxes
-€49,276
Result 2025
€271,335
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.4m
Investment
-€2.5m
Financing
+€1.1m
Cash 2024
€69,549
From operations (derived)
+€1.4m
Net result for the year
+€271,335
Depreciation
+€154,061
Receivables after one year
-€15,990
Receivables within one year
+€227,318
Deferred charges and accrued income
-€9,686
Provisions
-€10,962
Trade debts
+€328,274
Tax, wage and social debts
+€12,601
Other debts
+€409,104
Accrued charges and deferred income
+€1,582
Investment (derived)
-€2.5m
Investment in fixed assets (net)
-€2.5m
Financing
+€1.1m
Debts after one year
+€1.0m
Current portion of long-term debt
-€44,068
Short-term financial debts
+€88,493
Cash 2025
€16,015
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,794,145 | €10,880,897 | +€2.1m | +23.7% |
| Fixed assets | 21/28 | €7,188,561 | €9,530,489 | +€2.3m | +32.6% |
| Intangible fixed assets | 21 | €1,124 | €145 | -€979 | -87.1% |
| Tangible fixed assets | 22/27 | €3,434,570 | €5,530,109 | +€2.1m | +61.0% |
| Land and buildings | 22 | €2,562,082 | €2,464,155 | -€97,928 | -3.8% |
| Plant, machinery and equipment | 23 | €1,791 | €1,481 | -€311 | -17.3% |
| Furniture and vehicles | 24 | €42,124 | €26,831 | -€15,293 | -36.3% |
| Assets under construction and advance payments | 27 | €828,573 | €3,037,643 | +€2.2m | +267% |
| Financial fixed assets | 28 | €3,752,867 | €4,000,235 | +€247,368 | +6.6% |
| Current assets | 29/58 | €1,605,585 | €1,350,409 | -€255,176 | -15.9% |
| Amounts receivable after more than one year | 29 | €575,622 | €591,611 | +€15,990 | +2.8% |
| Other amounts receivable | 291 | €575,622 | €591,611 | +€15,990 | +2.8% |
| Amounts receivable within one year | 40/41 | €921,491 | €694,173 | -€227,318 | -24.7% |
| Trade receivables | 40 | €437,034 | €509,171 | +€72,137 | +16.5% |
| Other amounts receivable | 41 | €484,457 | €185,003 | -€299,454 | -61.8% |
| Current investments | 50/53 | €22,700 | €22,700 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €69,549 | €16,015 | -€53,534 | -77.0% |
| Deferred charges and accrued income | 490/1 | €16,223 | €25,909 | +€9,686 | +59.7% |
| Total equity and liabilities | 10/49 | €8,794,145 | €10,880,897 | +€2.1m | +23.7% |
| Equity | 10/15 | €3,560,700 | €3,832,035 | +€271,335 | +7.6% |
| Contributions | 10/11 | €18,550 | €18,550 | = | 0.0% |
| Reserves | 13 | €3,542,150 | €3,813,485 | +€271,335 | +7.7% |
| Tax-exempt reserves | 132 | €495,819 | €462,933 | -€32,886 | -6.6% |
| Distributable reserves | 133 | €3,046,330 | €3,350,552 | +€304,221 | +10.0% |
| Provisions and deferred taxes | 16 | €164,362 | €153,400 | -€10,962 | -6.7% |
| Deferred taxes | 168 | €164,362 | €153,400 | -€10,962 | -6.7% |
| Amounts payable | 17/49 | €5,069,083 | €6,895,462 | +€1.8m | +36.0% |
| Amounts payable after more than one year | 17 | €1,585,846 | €2,616,239 | +€1.0m | +65.0% |
| Financial debts | 170/4 | €1,585,846 | €2,616,239 | +€1.0m | +65.0% |
| Amounts payable within one year | 42/48 | €3,478,586 | €4,272,990 | +€794,403 | +22.8% |
| Current portion of amounts payable after more than one year | 42 | €574,003 | €529,935 | -€44,068 | -7.7% |
| Financial debts | 43 | €141,463 | €229,956 | +€88,493 | +62.6% |
| Credit institutions | 430/8 | €141,463 | €229,956 | +€88,493 | +62.6% |
| Trade debts | 44 | €197,915 | €526,188 | +€328,274 | +166% |
| Suppliers | 440/4 | €197,915 | €526,188 | +€328,274 | +166% |
| Taxes, remuneration and social security | 45 | €75,728 | €88,328 | +€12,601 | +16.6% |
| Taxes | 450/3 | €75,728 | €88,328 | +€12,601 | +16.6% |
| Other amounts payable | 47/48 | €2,489,478 | €2,898,582 | +€409,104 | +16.4% |
| Accrued charges and deferred income | 492/3 | €4,651 | €6,233 | +€1,582 | +34.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €159,433 | €154,061 | -€5,372 | -3.4% |
| Other operating charges | 640/8 | €35,925 | €29,856 | -€6,069 | -16.9% |
| Gross operating margin | 9900 | €425,832 | €635,995 | +€210,163 | +49.4% |
| Operating profit (loss) | 9901 | €230,473 | €452,078 | +€221,604 | +96.2% |
| Financial income | 75/76B | €26,035 | €17,239 | -€8,795 | -33.8% |
| Recurring financial income | 75 | €26,035 | €17,239 | -€8,795 | -33.8% |
| Financial charges | 65/66B | €92,794 | €93,806 | +€1,013 | +1.1% |
| Recurring financial charges | 65 | €92,794 | €93,806 | +€1,013 | +1.1% |
| Profit (loss) for the period before taxes | 9903 | €163,714 | €375,511 | +€211,797 | +129% |
| Transfer from deferred taxes | 780 | €10,962 | €10,962 | = | 0.0% |
| Income taxes | 67/77 | €65,862 | €115,138 | +€49,276 | +74.8% |
| Profit (loss) for the period | 9904 | €108,814 | €271,335 | +€162,521 | +149% |
| Transfer from tax-exempt reserves | 789 | €32,886 | €32,886 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €141,700 | €304,221 | +€162,521 | +115% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.